The global viral vectors and plasmid DNA manufacturing market was valued at $918.37 million in 2019, and is estimated to reach at $4,978.54 million by 2027, registering a CAGR of ...

According to a new market research report, ' Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, ...

Viral Vector Development MarketThe Viral Vector Development Market is set for impressive growth, with its valuation expected to rise from USD 730.7 million in 2023 to USD 4.1 billion by 2033, ...

Cellevate has launched its Cellevat3d nanofiber-based cell culture systems. They are designed to enable faster bioprocessing, more efficient scale up, and more viral vector yield. Cellevate asserts ...

Adds to Growing Portfolio of Intellectual Property AssetsATLANTA, Ga., Dec. 09, 2024 (GLOBE NEWSWIRE) -- GeoVax Labs, Inc. (Nasdaq: GOVX), a ...

Matica Biotechnology (Matica Bio), a leading contract development and manufacturing organization (CDMO) specializing in viral vector development and m ...